Page 470 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 470

32






                                      Approach to the Evaluation of the Patient

                                                  With Suspected Immunodeficiency



                                                                  Javier Chinen, Mary E. Paul, William T. Shearer







           Clinical immunologists are often consulted to evaluate patients    KEY CONCEPTS
           for suspected immune defects, usually because such patients
           have an unusual frequency or severity of infectious illnesses.   Secondary Immunodeficiencies
           Indeed, immunodeficiency presents with increased susceptibility   Immunodeficiency is often secondary or transient, caused by nonimmune
           to infection but may also manifest with conditions that reflect   factors, including:
           dysregulation of the immune response, such as allergies, autoim-  •  Previous use of high-dose steroids, or other immunosuppressive
           munity, or lymphoproliferation. Prompt diagnosis is essential to   medications
           reduce the risk of organ damage caused by preventable severe   •  Previous use of monoclonal antibodies (mAbs), such as rituximab
           infections. Primary immunodeficiencies (PIDs) are congenital   (anti-CD20)
           diseases that might affect any aspect of the immune response and   •  Immunoglobulin losses via the gastrointestinal or urinary tract
                                                                   •  Severe illness requiring critical care
           are often diagnosed in childhood. Examples of PIDs include severe   •  Malnutrition
           combined immune deficiencies (SCIDs), complete DiGeorge   •  Human immunodeficiency virus (HIV) infection
           syndrome, and chronic granulomatous disease (CGD). In
           contrast to PIDs, secondary immunodeficiencies (Chapters 38,
           39) present at any age, as a result of a wide variety of factors
           that affect the immune function, such as environmental factors,   increase the frequency of infections include allergic inflammation,
           metabolic disease, anatomical abnormalities, or infectious agents.   HIV infection, and the use of immunosuppressive drugs. Examples
           The most known and significant secondary immunodeficiency   of nonimmunological conditions include those that disrupt the
           is caused by human immunodeficiency virus (HIV). The assess-  usual mucosal clearance mechanisms, such as posterior urethral
           ment of a patient for PID should include history and physical   valves or urethral stenosis in a patient with recurrent urinary
           examination to direct immunology laboratory testing to confirm a    tract infection, or cystic fibrosis in individuals who have recurrent
           diagnosis.                                             sinusitis or pneumonia and/or diarrhea. Disruption of natural
                                                                  barriers can lead to increased risk of infection, for example, in
           EPIDEMIOLOGY—PRIMARY                                   patients with skin lesions caused by eczema or burns or in
           IMMUNODEFICIENCIES ARE NOT UNCOMMON                    individuals with cerebrospinal fluid (CSF) leaks following bony
                                                                  injury to the cranium. Patients presenting with low Ig levels
           Estimates of  the  incidence  of  PIDs  or  congenital  immuno-  might have loss of antibodies as a result of a protein-losing
           deficiencies varies from selective immunoglobulin  A (IgA)   enteropathy, nephropathy, or massive protein loss through skin,
                                                            1
                                                                                            5
           deficiency, a relatively common condition, (1/223–1/1000 people)    such as in severe eczema or burns.  Secondary immunodeficiency
           to the less common SCID. Recent analysis from 11 state programs   can also result from other conditions affecting cell metabolism
           established for universal newborn screening for T-cell deficiencies   (e.g., malnutrition, diabetes mellitus, and sickle cell anemia) or
           in the United States reported an incidence of SCID of 1/58 000   could be secondary to predictable or idiopathic adverse effects
                                                 2
           live births, comparable with childhood leukemia.  A household-  of drugs. Optimal management of these conditions often results
           based telephone survey suggested that 1 in 1200 persons in the   in improved immunity.
                                             3
           United States has been diagnosed with a PID.  Although significant
           progress has been made to stop the acquired immunodeficiency   EVALUATING PATIENTS FOR IMMUNODEFICIENCY
           syndrome (AIDS) epidemic, HIV infection continues to be the
           most prevalent cause of immunodeficiency worldwide, with an   The evaluation of patients for immunodeficiency is based on a
           estimated 36.9 million people living with HIV. 4       careful assessment of patient history and physical examination,
                                                                  with very limited initial laboratory testing. With this information,
           PRIMARY VERSUS SECONDARY                               the clinician can often tell patients (or parents) whether their
           IMMUNODEFICIENCY                                       (or their child’s) immune system is significantly compromised.
                                                                  The immunologist must take on a role of counselor and advisor
           Because  of  their  common  occurrence,  acquired  and  nonim-  of  patients  and  explain  the  many  factors  that  may  result  in
           munological causes for recurrent infections should be first   increased frequency of infections (Fig. 32.1). The limitations of
           considered  in  the  differential  diagnosis  of  the  patient  with  a   available clinically validated testing need to be considered, as
           suspected immune disorder.  Acquired conditions that might   such tests may not be sensitive or specific to identify uncommon

                                                                                                                451
   465   466   467   468   469   470   471   472   473   474   475